In today’s increasingly competitive and cost-constrained pharmaceutical landscape, gaining market access for innovative therapies is more challenging than ever. Regulatory variability, tighter healthcare budgets, and heightened scrutiny by HTA bodies demand a strategic, data-driven, and market-specific approach. This presentation will highlight the best-in-class approaches to crafting access strategies that align with payer expectations and patient needs. From early evidence generation to global pricing optimization, we will show how to empower pharma and biotech companies—large and small—to plan smarter, act earlier, and accelerate patient access where it matters most. In this session you will learn
- How to design an early market access strategy that aligns with evolving payer and HTA requirements across regions
- How to apply evidence planning tools—like mock scientific advice and HTA simulations—to strengthen your value proposition
- How to forecast pricing and reimbursement outcomes using analogue planning, competitive landscaping, and market-specific modeling
- How to communicate value through compelling, globally aligned dossiers and publication strategies that speak directly to decision-makers.
&nsbp;
